微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.3% | -63.86% | 105.73% | 55/71 | 2.21% | ST目药 | 9.27% | 行业排名> |
| 2024-12-31 | -5.24% | -1641.18% | -3182.35% | 56/71 | 3.08% | ST目药 | 22.26% | 行业排名> |
| 2024-09-30 | 0.17% | -90.71% | 30.77% | 59/71 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 0.13% | -86.73% | -84.34% | 57/71 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.83% | 419.23% | 144.12% | 52/71 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 0.34% | 325% | -81.42% | 55/71 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 1.83% | -16.06% | 86.73% | 57/71 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 0.98% | -15.52% | 476.92% | 58/71 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | -0.26% | -120.16% | -425% | 64/71 | 2.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 0.08% | -93.04% | -96.33% | 57/71 | 7.39% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 2.18% | -70.26% | 87.93% | 56/71 | 5.07% | 片仔癀 | 19.69% | 行业排名> |
| 2022-06-30 | 1.16% | -63.86% | -10.08% | 57/71 | 3.13% | 片仔癀 | 12.75% | 行业排名> |
| 2022-03-31 | 1.29% | -50.38% | 12.17% | 49/71 | 2.15% | 片仔癀 | 6.88% | 行业排名> |
| 2021-12-31 | 1.15% | -82.94% | -84.31% | 60/71 | 4.45% | 片仔癀 | 27.39% | 行业排名> |
| 2021-09-30 | 7.33% | 13.12% | 128.35% | 34/71 | 7.44% | 片仔癀 | 23.14% | 行业排名> |
| 2021-06-30 | 3.21% | -22.84% | 23.46% | 47/71 | 4.61% | 片仔癀 | 13.23% | 行业排名> |
| 2021-03-31 | 2.6% | 7.44% | -61.42% | 33/71 | -2.87% | *ST长药 | 7.37% | 行业排名> |
| 2020-12-31 | 6.74% | -32.06% | 4.01% | 36/71 | -2.08% | 沃华医药 | 22.84% | 行业排名> |
| 2020-09-30 | 6.48% | -30.1% | 55.77% | 35/71 | 5.56% | 沃华医药 | 19.47% | 行业排名> |
| 2020-06-30 | 4.16% | -12.24% | 71.9% | 31/71 | 3.25% | 沃华医药 | 12.7% | 行业排名> |
| 2020-03-31 | 2.42% | -15.38% | -75.6% | 24/71 | 1.91% | 济川药业 | 7.33% | 行业排名> |
| 2019-12-31 | 9.92% | 11.21% | 7.01% | 28/71 | 3.89% | 济川药业 | 27.43% | 行业排名> |
| 2019-09-30 | 9.27% | 11.69% | 95.57% | 18/71 | 7.09% | 济川药业 | 23.05% | 行业排名> |
| 2019-06-30 | 4.74% | 4.18% | 65.73% | 34/71 | 4.58% | 济川药业 | 15.79% | 行业排名> |
| 2019-03-31 | 2.86% | 47.42% | -67.94% | 30/71 | 2.86% | 华润三九 | 10.23% | 行业排名> |
| 2018-12-31 | 8.92% | -19.35% | 7.47% | 37/71 | 7.68% | 济川药业 | 32.79% | 行业排名> |
| 2018-09-30 | 8.3% | -13.36% | 82.42% | 27/71 | 7.89% | 济川药业 | 27.55% | 行业排名> |
| 2018-06-30 | 4.55% | -35.55% | 134.54% | 37/71 | 4.92% | 济川药业 | 17.62% | 行业排名> |
| 2018-03-31 | 1.94% | -31.21% | -82.46% | 41/71 | 2.71% | 济川药业 | 10.07% | 行业排名> |
| 2017-12-31 | 11.06% | 12.4% | 15.45% | 29/71 | 9.76% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-09-30 | 9.58% | 13.11% | 35.69% | 23/71 | 8.29% | 济川药业 | 24.2% | 行业排名> |
| 2017-06-30 | 7.06% | 32.21% | 150.35% | 21/71 | 5.16% | *ST大药 | 15.31% | 行业排名> |
| 2017-03-31 | 2.82% | 4.83% | -71.34% | 28/71 | 2.6% | 济川药业 | 14.64% | 行业排名> |
| 2016-12-31 | 9.84% | 171.07% | 16.17% | 33/71 | 9.95% | 济川药业 | 7.64% | 行业排名> |
| 2016-09-30 | 8.47% | -19.49% | 58.61% | 31/71 | 9.31% | 维康药业 | 38.23% | 行业排名> |
| 2016-06-30 | 5.34% | 7.01% | 98.51% | 31/71 | 5.02% | 太极集团 | 58.41% | 行业排名> |
| 2016-03-31 | 2.69% | -26.5% | -25.9% | 30/71 | 4.04% | 新光药业 | 16.54% | 行业排名> |
| 2015-12-31 | 3.63% | -81.37% | -65.49% | 56/71 | 11.27% | 太极集团 | 71.6% | 行业排名> |
| 2015-09-30 | 10.52% | -45.07% | 110.82% | 23/71 | 8.43% | 维康药业 | 48.67% | 行业排名> |
| 2015-06-30 | 4.99% | -53.84% | 36.34% | 34/71 | 5.48% | 济川药业 | 21.37% | 行业排名> |
| 2015-03-31 | 3.66% | -14.69% | -81.21% | 21/71 | 2.93% | 贵州三力 | 15.84% | 行业排名> |